undergo a tumour biopsy using a needle, or samples of the tumour are taken during surgery. A simple blood test or 'liquid biopsy' would make it much easier to identify patients who may benefit from Iressa, according to Mondher Mahjoubi, AZ's senior vice president, global product strategy for oncology.
